4.6 Review

Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 24, Issue 7, Pages 642-653

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2018.05.004

Keywords

-

Funding

  1. NIAMS
  2. NCI
  3. Parker Institute for Cancer Immunotherapy
  4. MSKCC Core grant [P30 CA008748]
  5. Damon Runyon Clinical Investigator Award

Ask authors/readers for more resources

Originally discovered as an inducer of apoptosis, the TNF-family receptor Fas (CD95, APO-1, TNFRSF6) has more recently been found to have functions beyond cell death, including T cell co-stimulation and promoting terminal differentiation of CD4(+) and CD8(+) T cells. Other TNF family members also discovered as apoptosis inducers, such as TRAIL (APO-2L, TNFSF10), can promote inflammation through caspase-8. Surprisingly, non-apoptotic signaling through Fas can protect from the autoimmunity seen in Fas deficiency independently from the cell death inducing functions of the receptor. Nonapoptotic Fas signaling can induce tumor cell growth and migration, and impair the efficacy of T cell adoptive immunotherapy. Blocking of non-apoptotic functions of these receptors may be a novel strategy to regulate autoimmunity and inflammation, and enhance antitumor immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available